Skip to main content
. 2023 Jun 7;37(10):1545–1553. doi: 10.1097/QAD.0000000000003620

Table 2.

Characteristics of participants.

All participants Chose LA-ART at least once Never chose LA-ART P-valuea
N 700 (100%) 626 (89%) 74 (11%)
Scenarios chose current therapy (mean, SD) 5.4 (6.4) 4.0 (5.3) 17.0 (0) <0.01
Survey duration in minutes (mean, SD) 30.5 (11.3) 30.6 (11.3) 29.4 (11.3) 0.37
Comprehension questions correct on first try, out of five questions (mean, SD) 4.5 (0.8) 4.5 (0.8) 4.2 (0.9) <0.01
Sociodemographic characteristics
 Washington State participant 350 (50%) 333 (53%) 17 (23%) <0.01
 Atlanta participant 350 (50%) 293 (47%) 57 (77%) <0.01
 Age in years (mean, SD) 48.6 (12.1) 48.1 (12.3) 53.4 (9.7) <0.01
 Black raceb 347 (50%) 297 (47%) 50 (68%) <0.01
 White raceb 279 (40%) 262 (42%) 17 (23%) <0.01
 Other raceb 90 (13%) 83 (13%) 7 (9%) 0.36
 Hispanic ethnicity 61 (9%) 57 (9%) 4 (5%) 0.29
 Female gender 168 (24%) 139 (22%) 29 (39%) <0.01
 Transgenderc 21 (3%) 19 (3%) 2 (3%) 0.87
 Heterosexual 227 (32%) 191 (31%) 36 (49%) <0.01
 Works full time 192 (27%) 182 (29%) 10 (14%) <0.01
 Education – high school or less 243 (35%) 196 (31%) 47 (64%) <0.01
 Income – less than $2000/month 438 (63%) 385 (62%) 53 (72%) 0.09
HIV-related characteristics
 Year since HIV diagnosis (mean, SD) 17.9 (9.8) 17.5 (9.8) 20.9 (9.2) <0.01
 Years on ART (mean, SD) 15.6 (8.7) 15.2 (8.6) 19.4 (8.5) <0.01
 ART for <5 years 63 (9%) 58 (9%) 5 (7%) 0.48
 Viral load ≤40 copies/mL 586 (84%) 525 (84%) 61 (82%) 0.75
 CD4 count <200 cells/μl 51 (7%) 47 (8%) 4 (5%) 0.51
 CD4 count 200–349 cells/μl 92 (13%) 82 (13%) 10 (14%) 0.92
 Past HIV regimens: 0 or 1 184 (26%) 160 (26%) 24 (32%) 0.20
 AIDS ever diagnosed 292 (42%) 262 (42%) 30 (41%) 0.83
 Good adherenced 370 (53%) 318 (51%) 52 (70%) <0.01
 Can get to HIV clinic easily 539 (77%) 478 (76%) 61 (82%) 0.24
Other health-related characteristics
 Injection drug use 18 (3%) 16 (3%) 2 (3%) 0.94
 Pills for non-HIV per day: 0 or 1 254 (36%) 229 (37%) 25 (34%) 0.64
 Aversion to injectionse 267 (38%) 222 (35%) 45 (61%) <0.01
 Substance usef
  Tobacco 117 (17%) 94 (15%) 23 (31%) <0.01
  Alcohol 61 (9%) 46 (7%) 15 (20%) <0.01
  Marijuana 21 (3%) 19 (3%) 2 (3%) 0.87
  Otherg 626 (89%) 558 (89%) 68 (92%) 0.47
 Mental health disordersf
  Depressiveh 297 (42%) 261 (42%) 36 (49%) 0.25
  Anxiety 136 (19%) 128 (20%) 8 (11%) 0.05
  PTSD 31 (4%) 28 (4%) 3 (4%) 0.87
  Psychosis 32 (5%) 30 (5%) 3 (4%) 0.42
Characteristics that participant preferred not to disclose
 Identity-relatedi 47 (7%) 42 (7%) 5 (7%) 0.99
 Income and work 79 (11%) 64 (10%) 15 (20%) 0.01
 Education 25 (4%) 19 (3%) 3 (4%) 0.03
 HIV-relatedj 14 (2%) 11 (2%) 3 (4%) 0.18
 AIDS – ever diagnosed 14 (2%) 13 (2%) 1 (1%) 0.67
 Other health-relatedk 14 (2%) 9 (1%) 5 (7%) <0.01
 No consent to link chart data 30 (4%) 25 (4%) 5 (7%) 0.27

Characteristics of 700 participants in a discrete choice experiment examining patient preferences for long-acting antiretroviral therapies. All participants were age 18+ and living with HIV. SD, standard deviation; LA-ART, long-acting antiretroviral therapy; PTSD, posttraumatic stress disorder.

a

P-values are from two-sided t-test for equality between Ever LA-ART and Never LA-ART.

b

Race categories were not mutually exclusive.

c

Transgender were individuals who self-reported as a transman or transwoman.

d

Good adherence was defined as reporting to always or almost always take ART as instructed.

e

Aversion to injections was defined as reporting strongly agree or somewhat agree with the statement ‘I HATE getting injections and try to avoid getting them whenever possible.’

f

Substance use and mental health disorders were extracted from medical chart review.

g

Other substances consist of benzodiazepines, cocaine, heroin, methamphetamines, opioids, or ‘other.’

h

Depressive mental health disorders included bipolar, dysthymia, depression, mood, and suicidality.

i

Identity-related characteristics included gender, sexual orientation, and race.

j

HIV-related characteristics (preferred not to disclose) included ART initiation year, HIV diagnosis year, number of past regimens, ART adherence, and getting to clinic easily.

k

Other health-related characteristics (preferred not to disclose) included number of non-HIV pills, and aversion to injections.